Pharmacokinetic overview of Ortho Evra™/Evra™
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Fertility and Sterility
- Vol. 77, 3-12
- https://doi.org/10.1016/s0015-0282(01)03261-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Pharmacokinetics of Norelgestromin and Ethinyl Estradiol Delivered by a Contraceptive Patch (Ortho Evra™/Evra™) under Conditions of Heat, Humidity, and ExerciseThe Journal of Clinical Pharmacology, 2001
- Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participantsContraception, 2001
- Pharmacokinetics of Norelgestromin and Ethinyl Estradiol from Two Consecutive Contraceptive PatchesThe Journal of Clinical Pharmacology, 2001
- Determination of norgestimate and its metabolites in human serum using high-performance liquid chromatography with tandem mass spectrometric detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimateAmerican Journal of Obstetrics and Gynecology, 1994
- Oral Contraceptive Drug InteractionsSouthern Medical Journal, 1991
- Pharmacologic and pharmacokinetic characteristics of norgestimate and its metabolitesAmerican Journal of Obstetrics and Gynecology, 1990
- Relative binding affinity of norgestimate and other progestins for human sex hormone-binding globulinSteroids, 1990
- Clinical and biochemical investigations of a variable-dose combined type oral contraceptiveCurrent Medical Research and Opinion, 1977
- SEX‐HORMONE‐BINDING GLOBULINClinical Endocrinology, 1974